Related Experiment Video
Updated: Aug 8, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
[Cell-mediated immunity in chronic pyelonephritis]
1Renal Division, Ren-Ji Hospital, Shanghai Second Medical University.
Insights
Chronic pyelonephritis (CPN) patients exhibit immune cell defects. Zi-Ling capsule (ZLC) and transfer factor (TF) with antibiotics improved immune function and CPN symptoms, particularly CD4 cells.
Area of Science:
- Immunology
- Nephrology
Context:
- Chronic pyelonephritis (CPN) is associated with altered immune responses.
- Peripheral blood lymphocyte surface markers provide insights into immune status.
Purpose:
- To investigate lymphocyte surface marker profiles in CPN patients.
- To evaluate the immunomodulatory effects of Zi-Ling capsule (ZLC)/transfer factor (TF) and antibiotics in CPN.
Summary:
- CPN patients showed decreased CD3, lower CD4, and higher CD8 counts, indicating cell-mediated immune defects.
- Treatment with ZLC/TF and antibiotics increased CD3 and CD4 counts, improving CPN symptoms.
- Immune improvements, particularly in CD4 cells, were transient after treatment cessation.
Impact:
- ZLC/TF combined with antibiotics may offer a therapeutic strategy for CPN by enhancing immune function.
- The study highlights the transient immunomodulatory effects of ZLC/TF on CD4 cells in CPN patients.
Abstract:
The authors used monoclonal antibody (CD3, CD4, CD8) and indirect immunofluorescence technic to study peripheral blood lymphocyte surface markers in patients with chronic pyelonephritis (CPN) and in normal controls. In CPN patients, a significant decrease in CD3, a lower percentage of CD4 and significant higher percentage of CD8 leading to a decrease in the CD4/CD8 ratio were noted. No differences could be observed between Spleen-Kidney Yang deficiency and Kidney Yin deficiency. The overall picture shown by the CPN patients was compatible to a cell-mediated immune response defection. The CPN patients were then treated with Zi-Ling capsule (ZLC)/transfer factor (TF) and various antibiotics for three months, during which period the authors found a significant increase in CD3, CD4, but no significant change in CD8. Symptoms such as lumbago, fatigue, frequency of urination were improved. A significant decreased in CD4 after cessation of treatment with ZLC and TF was observed. These observations suggested that both ZLC and TF could also improve the immune function, however, they mainly affect CD4 but not CD8 cells, and the effect lasted for only a short period. In conclusion, ZLC/TF and antibiotics administered together would serve as a useful therapeutic measure to be recommended for patients with CPN.
Related Concept Videos
Cell-mediated Immune Responses
Urinary Tract Infection II: Pathophysiology
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Chronic Inflammation: Introduction
Inflammatory Bowel Disease III: Crohn's Disease

